Angiotensin II type 2 receptor agonists: Where should they be applied?

Expert Opinion on Investigational Drugs

Volumn 21, Issue 4, 2012, Pages 501-513

  Verdonk, Koen ^a   Danser, A H Jan ^a   Van Esch, Joep H M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Angiotensin; Angiotensin II type 2 receptor agonist; C21; Heterodimer; Hypertrophy; Inflammation; Marfan's syndrome; Natriuresis; Neuroprotection; Vasorelaxation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR AGONIST; ANGIOTENSIN 2 RECEPTOR BINDING PROTEIN; ANGIOTENSIN III; C 21; COMPOUND 21; CYCLIC GMP; GUANINE NUCLEOTIDE BINDING PROTEIN; HETERODIMER; HORMONE RECEPTOR STIMULATING AGENT; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; NITRIC OXIDE; PHOSPHOPROTEIN PHOSPHATASE; PROMYELOCYTIC LEUKEMIA ZINC FINGER PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; BLOOD PRESSURE REGULATION; BRAIN; CARDIOVASCULAR SYSTEM; DIMERIZATION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG MECHANISM; ENZYME ACTIVATION; HEART; HEART ANEURYSM; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY; LIGAND BINDING; MEAN ARTERIAL PRESSURE; MOLECULAR BIOLOGY; NATRIURESIS; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; STROKE; VASOCONSTRICTION; VASODILATATION;

ANGIOTENSIN II; ANIMALS; HUMANS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 84858257624     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.2012.664131     Document Type: Review

References (169)

1. de Lannoy LM, Danser AHJ, van Kats JP, et al. Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I. Hypertension 1997;29:1240-51 (Pubitemid 27233172)
2. Danser AHJ, van Kats JP, Admiraal PJ, et al. Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension 1994;24:37-48 (Pubitemid 24195402)
3. van Kats JP, van Meegen JR, Verdouw PD, et al. Subcellular localization of angiotensin II in kidney and adrenal. J Hypertens 2001;19:583-9 (Pubitemid 32280950)
4. van Esch JHM, Gembardt F, Sterner-Kock A, et al. Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts. Cardiovasc Res 2010;86:401-9
5. Schuijt MP, Danser AHJ. Cardiac angiotensin II: an intracrine hormone? Am J Hypertens 2002;15:1109-16 (Pubitemid 35397547)
6. Campbell DJ, Kladis A, Duncan AM. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension 1993;22:513-22 (Pubitemid 23292157)
7. Katz SA, Opsahl JA, Lunzer MM, et al. Effect of bilateral nephrectomy on active renin, angiotensinogen, and renin glycoforms in plasma and myocardium. Hypertension 1997;30:259-66 (Pubitemid 27329007)
8. Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system in the heart. Curr Hypertens Rep 2009;11:104-10
9. Saris JJ, van den Eijnden MM, Lamers JM, et al. Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II. Hypertension 2002;39:573-7 (Pubitemid 34165185)
10. Chai W, Danser AHJ. Is angiotensin II made inside or outside of the cell? Curr Hypertens Rep 2005;7:124-7 (Pubitemid 40796732)
11. Silver RB, Reid AC, Mackins CJ, et al. Mast cells: a unique source of renin. Proc Natl Acad Sci USA 2004;101:13607-12 (Pubitemid 39238450)
12. Krop M, van Veghel R, Garrelds IM, et al. Cardiac Renin levels are not influenced by the amount of resident mast cells. Hypertension 2009;54:315-21
13. de Gasparo M, Catt KJ, Inagami T, et al. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000;52:415-72
14. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82-97 (Pubitemid 46127306)
15. van Kats JP, Duncker DJ, Haitsma DB, et al. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation 2000;102:1556-63
16. Batenburg WW, Garrelds IM, Bernasconi CC, et al. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation 2004;109:2296-301 (Pubitemid 38656868)
17. van Esch JHM, Schuijt MP, Sayed J, et al. AT(2) receptor-mediated vasodilation in the mouse heart depends on AT(1A) receptor activation. Br J Pharmacol 2006;148:452-8 (Pubitemid 43882081)
18. Padia SH, Howell NL, Siragy HM, Carey RM. Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat. Hypertension 2006;47:537-44 (Pubitemid 43843872)
19. Horiuchi M, Hayashida W, Kambe T, et al. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem 1997;272:19022-6 (Pubitemid 27318258)
20. van Kesteren CAM, van Heugten HAA, Lamers JMJ, et al. Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardiol 1997;29:2147-57 (Pubitemid 27348525)
21. Kurisu S, Ozono R, Oshima T, et al. Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension 2003;41:99-107 (Pubitemid 36056799)
22. Steckelings UM, Widdop RE, Paulis L, Unger T. The angiotensin AT2 receptor in left ventricular hypertrophy. J Hypertens 2010;28(Suppl 1):S50-5
23. Rompe F, Artuc M, Hallberg A, et al. Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension 2010;55:924-31
24. Duke LM, Widdop RE, Kett MM, Evans RG. AT(2) receptors mediate tonic renal medullary vasoconstriction in renovascular hypertension. Br J Pharmacol 2005;144:486-92 (Pubitemid 40352559)
25. Moltzer E, Verkuil AV, van Veghel R, et al. Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat. Loss of angiotensin II type 2 receptor-mediated vasodilation. Hypertension 2010;55:516-22
26. You D, Loufrani L, Baron C, et al. High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation 2005;111:1006-11 (Pubitemid 40354518)
27. Touyz RM, Endemann D, He G, et al. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension 1999;33:366-72 (Pubitemid 29065686)
28. Ichihara S, Senbonmatsu T, Price E Jr, et al. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 2001;104:346-51 (Pubitemid 32666959)
29. Senbonmatsu T, Ichihara S, Price E Jr, et al. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest 2000;106:R25-9 (Pubitemid 30655645)
30. Mukoyama M, Nakajima M, Horiuchi M, et al. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 1993;268:24539-42 (Pubitemid 23335456)
31. Millan MA, Jacobowitz DM, Aguilera G, Catt KJ. Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development. Proc Natl Acad Sci USA 1991;88:11440-4 (Pubitemid 21916057)
32. Tsutsumi K, Saavedra JM. Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain. Am J Physiol 1991;261:R209-16
33. Tsutsumi K, Saavedra JM. Characterization of AT2 angiotensin II receptors in rat anterior cerebral arteries. Am J Physiol 1991;261:H667-70
34. Sechi LA, Griffin CA, Grady EF, et al. Characterization of angiotensin II receptor subtypes in rat heart. Circ Res 1992;71:1482-9
35. Zhuo J, Dean R, MacGregor D, et al. Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature. Clin Exp Pharmacol Physiol 1996;23(Suppl 3):S147-54 (Pubitemid 26421908)
36. Shanmugam S, Lenkei ZG, Gasc JM, et al. Ontogeny of angiotensin II type 2 (AT2) receptor mRNA in the rat. Kidney Int 1995;47:1095-100
37. Grady EF, Sechi LA, Griffin CA, et al. Expression of AT2 receptors in the developing rat fetus. J Clin Invest 1991;88:921-33
38. Yu L, Zheng M, Wang W, et al. Developmental changes in AT1 and AT2 receptor-protein expression in rats. J Renin Angiotensin Aldosterone Syst 2010;11:214-21
39. Bottari SP, de Gasparo M, Steckelings UM, Levens NR. Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications. Front Neuroendocrinol 1993;14:123-71 (Pubitemid 23210953)
40. Silva-Antonialli MM, Tostes RC, Fernandes L, et al. A lower ratio of AT1/AT2 receptors of angiotensin II is found in female than in male spontaneously hypertensive rats. Cardiovasc Res 2004;62:587-93 (Pubitemid 38648973)
41. Sampson AK, Moritz KM, Jones ES, et al. Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats. Hypertension 2008;52:666-71
42. Ichiki T, Labosky PA, Shiota C, et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995;377:748-50
43. Hein L, Barsh GS, Pratt RE, et al. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995;377:744-7
44. Yamada H, Akishita M, Ito M, et al. AT2 receptor and vascular smooth muscle cell differentiation in vascular development. Hypertension 1999;33:1414-19 (Pubitemid 29282663)
45. Perlegas D, Xie H, Sinha S, et al. ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development. Am J Physiol Heart Circ Physiol 2005;288:H96-102 (Pubitemid 40023834)
46. Noda K, Feng YH, Liu XP, et al. The active state of the AT1 angiotensin receptor is generated by angiotensin II induction. Biochemistry 1996;35:16435-42 (Pubitemid 27020483)
47. Le MT, Vanderheyden PM, Szaszak M, et al. Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N-and C-terminal residues of angiotensin II during AT1 receptor activation. J Biol Chem 2002;277:23107-10 (Pubitemid 34952133)
48. Jones ES, Del Borgo MP, Kirsch JF, et al. A single beta-amino acid substitution to angiotensin II confers AT2 receptor selectivity and vascular function. Hypertension 2011;57:570-6
49. Miura S, Karnik SS. Angiotensin II type 1 and type 2 receptors bind angiotensin II through different types of epitope recognition. J Hypertens 1999;17:397-404 (Pubitemid 29116648)
50. Rosenstrom U, Skold C, Lindeberg G, et al. Synthesis and AT2 receptor-binding properties of angiotensin II analogues. J Pept Res 2004;64:194-201 (Pubitemid 39446661)
51. Miura S, Karnik SS, Saku K. Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. J Biol Chem 2005;280:18237-44 (Pubitemid 41389069)
52. Miura S, Karnik SS. Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. EMBO J 2000;19:4026-35 (Pubitemid 30608541)
53. Bosnyak S, Jones ES, Christopoulos A, et al. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin Sci (Lond) 2011;121:297-303
54. Bouley R, Perodin J, Plante H, et al. N-and C-terminal structure-activity study of angiotensin II on the angiotensin AT2 receptor. Eur J Pharmacol 1998;343:323-31 (Pubitemid 28138617)
55. Hansen JL, Servant G, Baranski TJ, et al. Functional reconstitution of the angiotensin II type 2 receptor and G(i) activation. Circ Res 2000;87:753-9
56. Padia SH, Kemp BA, Howell NL, et al. Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor mediated natriuresis in rats. Hypertension 2008;51:460-5 (Pubitemid 351156433)
57. van Esch JHM, Oosterveer CR, Batenburg WW, et al. Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT(2) receptor? Eur J Pharmacol 2008;588:286-93
58. Yatabe J, Yoneda M, Yatabe MS, et al. Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor. Endocrinology 2011;152:1582-8
59. Chiu AT, Herblin WF, McCall DE, et al. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989;165:196-203 (Pubitemid 20012475)
60. Zhang J, Pratt RE. The AT2 receptor selectively associates with Gialpha2 and Gialpha3 in the rat fetus. J Biol Chem 1996;271:15026-33
61. AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 2001;276:39721-6
62. Siragy HM, Carey RM. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 1997;100:264-9 (Pubitemid 27349072)
63. Abadir PM, Carey RM, Siragy HM. Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice. Hypertension 2003;42:600-4 (Pubitemid 37237360)
64. Cervenka L, Maly J, Karasova L, et al. Angiotensin II-induced hypertension in bradykinin B2 receptor knockout mice. Hypertension 2001;37:967-73 (Pubitemid 32221621)
65. Katada J, Majima M. AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br J Pharmacol 2002;136:484-91 (Pubitemid 34717692)
66. Tsutsumi Y, Matsubara H, Masaki H, et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 1999;104:925-35 (Pubitemid 29536342)
67. Ritter O, Schuh K, Brede M, et al. AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathway. FASEB J 2003;17:283-5
68. Madrid MI, Garcia-Salom M, Tornel J, et al. Effect of interactions between nitric oxide and angiotensin II on pressure diuresis and natriuresis. Am J Physiol 1997;273:R1676-82 (Pubitemid 27518118)
69. Siragy HM, Inagami T, Carey RM. NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats. Am J Physiol Regul Integr Comp Physiol 2007;293:R1461-7 (Pubitemid 47535763)
70. Horiuchi M, Akishita M, Dzau VJ. Molecular and cellular mechanism of angiotensin II-mediated apoptosis. Endocr Res 1998;24:307-14 (Pubitemid 29016402)
71. Miyamoto N, Zhang N, Tanaka R, et al. Neuroprotective role of angiotensin II type 2 receptor after transient focal ischemia in mice brain. Neurosci Res 2008;61:249-56
72. Horiuchi M, Hayashida W, Akishita M, et al. Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk. Circ Res 1999;84:876-82 (Pubitemid 29196731)
73. Tani T, Ayuzawa R, Takagi T, et al. Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cells. Mol Cell Biochem 2008;315:185-93
74. Wu L, Iwai M, Li Z, et al. Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells. Mol Endocrinol 2004;18:666-78 (Pubitemid 38328210)
75. Kohout TA, Rogers TB. Angiotensin II activates the Na +HCO3-symport through a phosphoinositide-independent mechanism in cardiac cells. J Biol Chem 1995;270:20432-8
76. Lokuta AJ, Cooper C, Gaa ST, et al. Angiotensin II stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells. J Biol Chem 1994;269:4832-8 (Pubitemid 24239457)
77. Dulin NO, Alexander LD, Harwalkar S, et al. Phospholipase A2-mediated activation of mitogen-activated protein kinase by angiotensin II. Proc Natl Acad Sci USA 1998;95:8098-102 (Pubitemid 28326072)
78. Rompe F, Unger T, Steckelings UM. The angiotensin AT2 receptor in inflammation. Drug News Perspect 2010;23:104-11
79. Arima S, Endo Y, Yaoita H, et al. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1997;100:2816-23 (Pubitemid 28007551)
80. Batenburg WW, Tom B, Schuijt MP, Danser AHJ. Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s). Vascul Pharmacol 2005;42:109-18 (Pubitemid 40417710)
81. Barna M, Hawe N, Niswander L, Pandolfi PP. Plzf regulates limb and axial skeletal patterning. Nat Genet 2000;25:166-72 (Pubitemid 30394986)
82. Senbonmatsu T, Saito T, Landon EJ, et al. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J 2003;22:6471-82 (Pubitemid 38009595)
83. Yeyati PL, Shaknovich R, Boterashvili S, et al. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 1999;18:925-34 (Pubitemid 29086269)
84. Seidel K, Kirsch S, Lucht K, et al. The promyelocytic leukemia zinc finger (PLZF) protein exerts neuroprotective effects in neuronal cells and is dysregulated in experimental stroke. Brain Pathol 2011;21:31-43
85. Schefe JH, Unger T, Funke-Kaiser H. PLZF and the (pro)renin receptor. J Mol Med 2008;86:623-7
86. Widdop RE, Matrougui K, Levy BI, Henrion D. AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension 2002;40:516-20
87. Wruck CJ, Funke-Kaiser H, Pufe T, et al. Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol 2005;25:57-64 (Pubitemid 40054254)
88. Nouet S, Amzallag N, Li JM, et al. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 2004;279:28989-97 (Pubitemid 38915768)
89. Di Benedetto M, Bieche I, Deshayes F, et al. Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene 2006;380:127-36 (Pubitemid 44363148)
90. Miura S, Matsuo Y, Kiya Y, et al. Molecular mechanisms of the antagonistic action between AT1 and AT2 receptors. Biochem Biophys Res Commun 2010;391:85-90
91. Abadir PM, Periasamy A, Carey RM, Siragy HM. Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension 2006;48:316-22 (Pubitemid 44309829)
92. McMullen JR, Gibson KJ, Lumbers ER, et al. Interactions between AT1 and AT2 receptors in uterine arteries from pregnant ewes. Eur J Pharmacol 1999;378:195-202 (Pubitemid 29356016)
93. Touyz RM, Endemann D, He G, et al. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension 1999;33:366-72 (Pubitemid 29065686)
94. Nora EH, Munzenmaier DH, Hansen-Smith FM, et al. Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle. Am J Physiol 1998;275:H1395-403
95. Matrougui K, Loufrani L, Heymes C, et al. Activation of AT(2) receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension 1999;34:659-65 (Pubitemid 29496450)
96. Yayama K, Horii M, Hiyoshi H, et al. Up-regulation of angiotensin II type 2 receptor in rat thoracic aorta by pressure-overload. J Pharmacol Exp Ther 2004;308:736-43 (Pubitemid 38134238)
97. Suzuki J, Iwai M, Nakagami H, et al. Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation. Circulation 2002;106:847-53
98. Schinzari F, Tesauro M, Rovella V, et al. Coexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans. J Hypertens 2011;29:1743-8
99. Savoia C, Touyz RM, Volpe M, Schiffrin EL. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension 2007;49:341-6 (Pubitemid 46143011)
100. Sohn HY, Raff U, Hoffmann A, et al. Differential role of angiotensin II receptor subtypes on endothelial superoxide formation. Br J Pharmacol 2000;131:667-72
101. Dimitropoulou C, White RE, Fuchs L, et al. Angiotensin II relaxes microvessels via the AT(2) receptor and Ca(2+)-activated K(+) (BK(Ca)) channels. Hypertension 2001;37:301-7 (Pubitemid 32199091)
102. Hunley TE, Tamura M, Stoneking BJ, et al. The angiotensin type II receptor tonically inhibits angiotensin-converting enzyme in AT2 null mutant mice. Kidney Int 2000;57:570-7 (Pubitemid 30430649)
103. Pinaud F, Bocquet A, Dumont O, et al. Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats. Hypertension 2007;50:96-102 (Pubitemid 46986016)
104. Cosentino F, Savoia C, De Paolis P, et al. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Am J Hypertens 2005;18:493-9
105. Nakajima M, Hutchinson HG, Fujinaga M, et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 1995;92:10663-7
106. Akishita M, Iwai M, Wu L, et al. Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation 2000;102:1684-9
107. Wu L, Iwai M, Nakagami H, et al. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 2001;104:2716-21 (Pubitemid 33108140)
108. Habashi JP, Doyle JJ, Holm TM, et al. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 2011;332:361-5
109. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998;83:1182-91 (Pubitemid 29006033)
110. Regitz-Zagrosek V, Friedel N, Heymann A, et al. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 1995;91:1461-71
111. Asano K, Dutcher DL, Port JD, et al. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation 1997;95:1193-200 (Pubitemid 27097830)
112. Haywood GA, Gullestad L, Katsuya T, et al. AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation 1997;95:1201-6 (Pubitemid 27097831)
113. Tsutsumi Y, Matsubara H, Ohkubo N, et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res 1998;83:1035-46 (Pubitemid 28520933)
114. Wharton J, Morgan K, Rutherford RA, et al. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. J Pharmacol Exp Ther 1998;284:323-36 (Pubitemid 28109563)
115. Lee S, Kramer CM, Mankad S, et al. Combined angiotensin converting enzyme inhibition and angiotensin AT(1) receptor blockade up-regulates myocardial AT(2) receptors in remodeled myocardium post-infarction. Cardiovasc Res 2001;51:131-9 (Pubitemid 32523062)
116. Masaki H, Kurihara T, Yamaki A, et al. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest 1998;101:527-35 (Pubitemid 28084234)
117. Sasaoka T, Egi Y, Tawa M, et al. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts. J Cardiovasc Pharmacol 2008;52:176-83
118. Yang Z, Bove CM, French BA, et al. Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation 2002;106:106-11 (Pubitemid 34747449)
119. Bove CM, Yang Z, Gilson WD, et al. Nitric oxide mediates benefits of angiotensin II type 2 receptor overexpression during post-infarct remodeling. Hypertension 2004;43:680-5 (Pubitemid 38282447)
120. Senbonmatsu T, Ichihara S, Price E Jr, et al. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest 2000;106:R25-9 (Pubitemid 30655645)
121. Gross V, Schunck WH, Honeck H, et al. Inhibition of pressure natriuresis in mice lacking the AT2 receptor. Kidney Int 2000;57:191-202 (Pubitemid 30227766)
122. Padia SH, Kemp BA, Howell NL, et al. Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type 1 receptor-blocked rats. Hypertension 2007;49:625-30
123. Padia SH, Kemp BA, Howell NL, et al. Intrarenal angiotensin III infusion induces natriuresis and angiotensin type 2 receptor translocation in Wistar-Kyoto but not in spontaneously hypertensive rats. Hypertension 2009;53:338-43
124. Padia SH, Howell NL, Kemp BA, et al. Intrarenal aminopeptidase N inhibition restores defective angiontesin II type 2-mediated natriuresis in spontaneously hypertensive rats. Hypertension 2010;55:474-80
125. Haithcock D, Jiao H, Cui XL, et al. Renal proximal tubular AT2 receptor: signaling and transport. J Am Soc Nephrol 1999;10(Suppl 11):S69-74 (Pubitemid 29038167)
126. Hakam AC, Hussain T. Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway. Am J Physiol Renal Physiol 2006;290:F1430-6 (Pubitemid 43830769)
127. Sakai N, Wada T, Matsushima K, et al. The renin-angiotensin system contributes to renal fibrosis through regulation of fibrocytes. J Hypertens 2008;26:780-90 (Pubitemid 351354927)
128. Kaschina E, Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press 2003;12:70-88 (Pubitemid 36700689)
129. Pawlowski TL, Heringer-Walther S, Cheng CH, et al. Candidate Agtr2 influenced genes and pathways identified by expression profiling in the developing brain of Agtr2(-/y) mice. Genomics 2009;94:188-95
130. Li Z, Iwai M, Wu L, et al. Role of AT2 receptor in the brain in regulation of blood pressure and water intake. Am J Physiol Heart Circ Physiol 2003;284:H116-21 (Pubitemid 36076277)
131. Lenkei Z, Palkovits M, Corvol P, Llorens-Cortes C. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol 1997;18:383-439 (Pubitemid 27463182)
132. Vervoort VS, Beachem MA, Edwards PS, et al. AGTR2 mutations in X-linked mental retardation. Science 2002;296:2401-3 (Pubitemid 34734216)
133. AbdAlla S, Lother H, el Missiry A, et al. Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. J Biol Chem 2009;284:6554-65
134. AbdAlla S, Lother H, el Missiry A, et al. Dominant negative AT2 receptor oligomers induce G-protein arrest and symptoms of neurodegeneration. J Biol Chem 2009;284:6566-74
135. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003 (Pubitemid 34286536)
136. Lu Q, Zhu YZ, Wong PT. Angiotensin receptor gene expression in candesartan mediated neuroprotection. Neuroreport 2004;15:2643-6 (Pubitemid 40053954)
137. Li J, Culman J, Hortnagl H, et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. Faseb J 2005;19:617-19 (Pubitemid 40471263)
138. Lucius R, Gallinat S, Rosenstiel P, et al. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med 1998;188:661-70 (Pubitemid 28387929)
139. Iwai M, Liu HW, Chen R, et al. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 2004;110:843-8 (Pubitemid 39096013)
140. Cote F, Laflamme L, Payet MD, Gallo-Payet N. Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells. Endocr Res 1998;24:403-7 (Pubitemid 29016414)
141. Cote F, Do TH, Laflamme L, et al. Activation of the AT(2) receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum. J Biol Chem 1999;274:31686-92
142. Ardaillou R, Chansel D. Synthesis and effects of active fragments of angiotensin II. Kidney Int 1997;52:1458-68 (Pubitemid 28032049)
143. Loufrani L, Henrion D, Chansel D, et al. Functional evidence for an angiotensin IV receptor in rat resistance arteries. J Pharmacol Exp Ther 1999;291:583-8 (Pubitemid 29503528)
144. Vinh A, Widdop RE, Drummond GR, Gaspari TA. Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice. Cardiovasc Res 2008;77:178-87 (Pubitemid 351195149)
145. Saraiva VB, de Souza Silva L, Ferreira-DaSilva CT, et al. Impairment of the Plasmodium falciparum erythrocytic cycle induced by angiotensin peptides. PLoS One 2011;6:e17174
146. Tesanovic S, Vinh A, Gaspari TA, et al. Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2010;30:1606-13
147. Stoll M, Steckelings UM, Paul M, et al. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995;95:651-7
148. Carey RM, Howell NL, Jin XH, Siragy HM. Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats. Hypertension 2001;38:1272-7 (Pubitemid 34033401)
149. Barber MN, Sampey DB, Widdop RE. AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats. Hypertension 1999;34:1112-16
150. Li XC, Widdop RE. AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR. Br J Pharmacol 2004;142:821-30 (Pubitemid 38998096)
151. Laflamme L, Gasparo M, Gallo JM, et al. Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors. J Biol Chem 1996;271:22729-35 (Pubitemid 26304718)
152. Meffert S, Stoll M, Steckelings UM, et al. The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol Cell Endocrinol 1996;122:59-67 (Pubitemid 26328859)
153. McCarthy CA, Vinh A, Callaway JK, Widdop RE. Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke 2009;40:1482-9
154. Abadir PM, Walston JD, Carey RM, Siragy HM. Angiotensin II Type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFalpha production. J Interferon Cytokine Res 2011;31:471-4
155. Wan Y, Wallinder C, Plouffe B, et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem 2004;47:5995-6008 (Pubitemid 39507341)
156. Wan Y, Wallinder C, Johansson B, et al. First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivo. J Med Chem 2004;47:1536-46 (Pubitemid 38327477)
157. Kivlighn SD, Huckle WR, Zingaro GJ, et al. Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin II. Am J Physiol 1995;268:R820-3
158. Perlman S, Schambye HT, Rivero RA, et al. Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor. J Biol Chem 1995;270:1493-6
159. Bosnyak S, Welungoda IK, Hallberg A, et al. Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br J Pharmacol 2010;159:709-16
160. Gelosa P, Pignieri A, Fandriks L, et al. Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage. J Hypertens 2009;27:2444-51
161. Matavelli LC, Huang J, Siragy HM. Angiotensin AT receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension 2011;57:308-13
162. Kaschina E, Grzesiak A, Li J, et al. Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 2008;118:2523-32
163. Jehle AB, Xu Y, Dimaria JM, et al. A non-peptide Angiotensin II type 2 receptor agonist does not attenuate post-myocardial infarction left ventricular remodeling in mice. J Cardiovasc Pharmacol 2011 [In press]
164. Hilliard LM, Jones ES, Steckelings UM, et al. Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: a novel therapeutic target for hypertension. Hypertension 2012;59:409-14
165. Rehman A, Leibowitz A, Yamamoto N, et al. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 2012;59:291-9
166. Jing F, Mogi M, Sakata A, et al. Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J Cereb Blood Flow Metab 2012;32:248-55
167. Hilliard LM, Nematbakhsh M, Kett MM, et al. Gender differences in pressure-natriuresis and renal autoregulation: role of the Angiotensin type 2 receptor. Hypertension 2011;57:275-82
168. Moltzer E, Essers J, van Esch JHM, et al. The role of the renin-angiotensin system in thoracic aortic aneurysms: clinical implications. Pharmacol Ther 2011;131:50-60
169. Steckelings UM, Paulis L, Unger T, Bader M. Emerging drugs which target the renin-angiotensin-aldosterone system. Expert Opin Emerg Drugs 2011;16:619-30